findmyKOL
Clinical trialNCT00462046CompletedPhase 3Interventional

Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia

SponsorShanghai Jiao Tong University School of MedicineEnrollment120Diabetes Mellitus, Type 2Metabolic Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Xiao-Ying Li, MD,PhD

    Shanghai Jiao Tong University School of Medicine

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2005
Primary completion
Completion
30 Sept 2006
Last update posted
18 Apr 2007
Registered enrollment
120
Registry id
NCT00462046

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.